RE:RE:RE:RE:RE:RE:RE:RE:RE:Share Price (Unbiased Opionion)No I don’t think so.
i just wanted to Say that RepliCel knows how they promote RCI-02, RCS, RCT and further development
the Big problem and question is SHISEIDO. I have no problem to wait until the stock goes up and I get money.
but I have a problem if I loose hair every single day and there could have been a solution for me since 1 year and a business fight is the reason for becoming bald.
I have to repeat: RCH-01 is a maintenance treatment, maybe some regrowth. But more than 30% regrowth isn’t possible I think. A 40 year old bald man won’t be able to get his hair back.
and the „significant results“ which was shown in the RCS trial could mean everything.
in the phase 1 study of RCH-01 there was also mentioned „significant results“ but this was „only“ 11% average regrowth which is not significant in my opinion. If SHISEIDO waits another couple of months there will come other players to the market with possibility to regrowth a full head of hair (Kyocera) or developing 10.000 follicles out of 30 donor follicles (TissUse/J hewitt). If this is the case, RCH-01 would not be worth so much money. You have to think about that